Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:INFI

Infinity Pharmaceuticals (INFI) Stock Price, News & Analysis

Infinity Pharmaceuticals logo

About Infinity Pharmaceuticals Stock (NASDAQ:INFI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.01
$0.13
52-Week Range
N/A
Volume
2.48 million shs
Average Volume
2.58 million shs
Market Capitalization
$726 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INFI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Infinity Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

INFI Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Woman shot while driving in South Memphis
See More Headlines

INFI Stock Analysis - Frequently Asked Questions

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced its quarterly earnings data on Tuesday, November, 2nd. The biotechnology company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.02. The biotechnology company had revenue of $0.43 million for the quarter, compared to analyst estimates of $0.45 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Infinity Pharmaceuticals investors own include Digital Turbine (APPS), ChargePoint (CHPT), CrowdStrike (CRWD), Vuzix (VUZI) and Sangamo Therapeutics (SGMO).

Company Calendar

Last Earnings
11/02/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:INFI
CIK
1113148
Employees
30
Year Founded
2000

Profitability

EPS (Trailing Twelve Months)
($0.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$44.37 million
Net Margins
-1,593.93%
Pretax Margin
-1,593.93%
Return on Equity
N/A
Return on Assets
-113.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$2.59 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.21) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
90,760,000
Free Float
81,857,000
Market Cap
$726 thousand
Optionable
Optionable
Beta
1.63

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:INFI) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners